MAURI FREITAS: Open Payments
NPI 1760011811 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,517 in 133 payments from 28 companies in 2025. Trend: 2023 $1,542 · 2024 $1,771 · 2025 $2,517
Food & beverage: $2,517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $375 |
| PFIZER INC. | 17 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $201 |
| Novo Nordisk Inc | 11 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $137 |
| Antares Pharma, Inc. | 8 | $135 |
| Lilly USA, LLC | 6 | $109 |
| Amneal Pharmaceuticals LLC | 6 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Axsome Therapeutics, Inc. | 4 | $87 |
Products named: NURTEC ODT, TRINTELLIX, UBRELVY, ELIQUIS, CAPLYTA, XYOSTED, UNITHROID, QULIPTA.
Industry payments across LA — which companies pay providers there.
